Unapproved therapeutic goods
There are a number of ways that patients can gain access to products that have not been approved for use in Australia.
Medicinal cannabis, nicotine, MDMA and psilocybin
Latest alerts
- EVE Allylisopropylacetylurea tabletsThe TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
- Counterfeit semaglutide vialsThe TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
- Antibiotics shortage update and substitution allowed to address shortage of cefaclorWe continue to monitor antibiotic medicines in shortage and are seeking and prioritising applications for overseas alternatives to assist with supply.
Latest articles
- Warnings on supply and advertising of ‘Haytox’‘Haytox’ has not been approved by the TGA or included in the Australian Register of Therapeutic Goods (ARTG).
TGA seizes 70,000 vapes in NSWWe have executed warrants on storage units in Sydney and seized more than 70,000 vaping products, with an estimated street value of over $2.1 million. They will be tested for dangerous and undeclared chemicals at our labs.- Nius Development Pty Ltd fined $26,640 for allegedly importing unapproved cosmetic injectable productsWe have issued infringement notices for $26,640 to Nius Development Pty Ltd for the alleged unlawful import of unapproved cosmetic injectable products.
Latest publications
- Nicotine Vaping Product Analysis: Evidence from the University of WollongongThis document contains practical information produced by a team from the University of Wollongong, based on their years of practical research on nicotine vaping products.
- Testing of paediatric medicinal cannabis products being supplied via SAS in AustraliaThe TGA has released a report on the laboratory testing of SAS-supplied cannabis products.
- Testing for toxins in medicinal cannabis products being supplied via SAS B in AustraliaThe TGA has released a report on the laboratory testing for toxins in medicinal cannabis products.